Madagascar Institute for Vaccine Research

University of Antananarivo - IVI Collaborating Center

IVI and the University of Antananarivo (UoA) in Madagascar have a longstanding partnership in vaccine development and infectious disease research. Learn more about IVI programs in Madagascar.

In December 2021, the UoA-IVI Collaborating Center – officially named the Madagascar Institute for Vaccine Research (MIVR) – opened and began operations at the UoA in Madagascar.

A new building on the premises of the UoA was constructed using overhead (indirect) cost funding from ongoing and upcoming projects. This newly established center supports the university with additional educational capacity and helps Madagascar establish a center of excellence for vaccine research including the conduct of clinical trials.

MIVR activities include:

  • Implementation of collaborative programs
  • Development and submission of proposals for future research and study programs
  • Development of academic programs, including teaching and scholarly initiatives
  • Seconding and exchange of staff

Collaborative programs

MIVR has hosted a range of collaborative programs, including:

  • COVID-19 Research in African Settings (COVIA)
  • Typhoid Conjugate Vaccine Introduction in Africa program (THECA)
  • Severe Typhoid in Africa (SETA) Plus
  • Vaccines Against Schistosomiasis for Africa (VASA)

Contact information

Madagascar Institute for Vaccine Research
Présidence de l'Université d'Antananarivo: BP 566 Antananarivo, 101, Madagascar
T: +261 20 22 326 39